These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8004978)

  • 1. Matrix metalloproteinases. A mini-review.
    Nagase H
    Contrib Nephrol; 1994; 107():85-93. PubMed ID: 8004978
    [No Abstract]   [Full Text] [Related]  

  • 2. [Focalized matrix proteolysis and inflammation].
    Gaudin P; Trocmé C; Monier F; Zaoui P; Barro C; Polack B; Hadjian A; Berthier S; Morel F
    Ann Biol Clin (Paris); 1998; 56(6):661-9. PubMed ID: 9853025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The matrix-degrading metalloproteinases.
    Matrisian LM
    Bioessays; 1992 Jul; 14(7):455-63. PubMed ID: 1445287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of extracellular matrix metalloproteases by proteases and organomercurials.
    Grant GA; Goldberg GI; Wilhelm SM; He C; Eisen AZ
    Matrix Suppl; 1992; 1():217-23. PubMed ID: 1480030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts.
    Moore WG; Birkedal-Hansen B; Pierson M; Birkedal-Hansen H
    Matrix Suppl; 1992; 1():319-20. PubMed ID: 1480050
    [No Abstract]   [Full Text] [Related]  

  • 6. Matrix metalloproteinases and their inhibitors.
    Murphy G
    Acta Orthop Scand Suppl; 1995 Oct; 266():55-60. PubMed ID: 8553862
    [No Abstract]   [Full Text] [Related]  

  • 7. Complex roles of matrix metalloproteinases in tumor progression.
    Powell WC; Matrisian LM
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():1-21. PubMed ID: 8814982
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
    Woessner JF
    FASEB J; 1991 May; 5(8):2145-54. PubMed ID: 1850705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sea urchin hatching enzyme (envelysin): cDNA cloning and deprivation of protein substrate specificity by autolytic degradation.
    Nomura K; Shimizu T; Kinoh H; Sendai Y; Inomata M; Suzuki N
    Biochemistry; 1997 Jun; 36(23):7225-38. PubMed ID: 9188724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H; Werle K; Bauer MM; Dollinger H; Jung B
    J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of a novel mid-gut procarboxypeptidase from the cotton pest Helicoverpa armigera.
    Estébanez-Perpiñá E; Bayés A; Vendrell J; Jongsma MA; Bown DP; Gatehouse JA; Huber R; Bode W; Avilés FX; Reverter D
    J Mol Biol; 2001 Oct; 313(3):629-38. PubMed ID: 11676544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the substrate specificity of bone morphogenetic protein 1/tolloid-like metalloproteases.
    Mac Sweeney A; Gil-Parrado S; Vinzenz D; Bernardi A; Hein A; Bodendorf U; Erbel P; Logel C; Gerhartz B
    J Mol Biol; 2008 Dec; 384(1):228-39. PubMed ID: 18824173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A matrix metalloproteinase proenzyme activator produced by articular cartilage.
    Towle CA; Wright M; Hecht AC; Kuong SJ; Papanicolas LE; Totkovic R; Mankin HJ; Treadwell BV
    Biochem Biophys Res Commun; 1998 Jun; 247(2):324-31. PubMed ID: 9642125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of the reprolysin atrolysin C and tissue inhibitors of metalloproteinases (TIMPs) interaction.
    Pinto AF; Terra RM; Guimarães JA; Kashiwagi M; Nagase H; Serrano SM; Fox JW
    Biochem Biophys Res Commun; 2006 Sep; 347(3):641-8. PubMed ID: 16842758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The matrix metalloproteinases and their inhibitors.
    Murphy G; Docherty AJ
    Am J Respir Cell Mol Biol; 1992 Aug; 7(2):120-5. PubMed ID: 1497900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of the metalloproteinases and renal extracellular matrix accumulation.
    Jones CL; Fecondo J; Kelynack K; Forbes J; Walker R; Becker G
    Exp Nephrol; 1995; 3(2):80-6. PubMed ID: 7773641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.